Novartis to manufacture CureVac’s Covid-19 vaccine candidate CVnCoV
Novartis will manufacture the mRNA and bulk drug product for up to 50 million doses of the CVnCoV…
GSK, Vir expand collaboration to develop therapies for respiratory viruses
18 Feb 21The companies initially signed an agreement in April 2020 to discover and develop new therapies for coronaviruses
AstraZeneca closes sale of Crestor rights in Europe to Grünenthal
11 Feb 21Crestor is a statin, a lipid-lowering medicine intended to treat blood lipid disorders and prevent cardiovascular events, such…
CureVac, UK Government partner to develop multi-variant Covid-19 vaccines
08 Feb 21Under the agreement, CureVac will initially supply 50 million doses of multi-variant Covid-19 vaccines to the UK with…
Philips, Dutch SAZ hospital network partner for connected care solutions
05 Feb 21SAZ hospitals will use Philips solutions for patient monitoring and self-management
GSK, CureVac team up to develop multi-variant Covid-19 vaccines
04 Feb 21GSK will assist in the production of up to 100 million doses of CureVac’s first-generation Covid-19 vaccine CVnCoV…
GSK to transfer malaria vaccine manufacturing to Bharat Biotech
28 Jan 21GSK will transfer the production of the RTS,S antigen to Bharat Biotech, while it will retain the manufacturing…
Lilly, Merus collaborate on T-Cell re-directing bispecific antibody therapies
20 Jan 21The research and license collaboration aims to research and develop up to three CD3-engaging T-cell re-directing bispecific antibody…
Vir-GSK partnership to begin AGILE study of early treatment for Covid-19
13 Jan 21VIR-7832 is the second monoclonal antibody from Vir-GSK collaboration, and the study is expected to commence in Q1…
Novartis collaborates with BeiGene for cancer drug tislelizumab
12 Jan 21The collaboration will help Novartis expand its oncology portfolio with late-stage PD-1 for monotherapy and potential PD-1 combinations